CD24 and breast carcinoma: In addition, differentiated cancer cells may acquire stem-like characteristics due to this selective pressure.[32] Consistently, the loss of CD24 in breast cancer cells is reported to be related to therapy resistance by inducing stemness properties.[33] These findings suggest CD24 might be an earlier parameter for predicting therapy resistance.